Literature DB >> 11508392

Mouse model for Chagas disease: immunohistochemical distribution of different stages of Trypanosoma cruzi in tissues throughout infection.

J Guarner1, J Bartlett, S R Zaki, D G Colley, M J Grijalva, M R Powell.   

Abstract

Different stages of Trypanosoma cruzi are seen during mammalian infection. Histologic sections of infected hearts have shown amastigotes and, when using immunohistochemistry (IHC), parasite antigens; however, demonstration of trypomastigotes in these tissues has proven elusive. Using a mouse strain that develops chagasic cardiomyopathy (histologically similar to human infection) 70 days after injecting T. cruzi-Brazil strain, we studied the distribution of parasite stages and the extent of inflammation. All organs had varying amounts of mononuclear inflammation by day 10, which peaked between day 20 and day 30, and decreased by day 50. Amastigotes were detected in myocytes, histiocytes, acinar pancreatic cells, astrocytes and ependymal cells by day 10, and the number of amastigotes peaked on day 30. Immunohistochemistry demonstrated trypomastigotes in sinusoids, vessels and interstitial tissues of several organs between day 15 and 50. Abundant parasite antigens (granular staining) were detected in connective tissues throughout the infection. The burden of amastigotes and trypomastigotes during the acute phase seems to correlate with the degree of inflammation and granular staining in the chronic stage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508392     DOI: 10.4269/ajtmh.2001.65.152

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Characterization of Trypanosoma cruzi infectivity, proliferation, and cytokine patterns in gut and pancreatic epithelial cells maintained in vitro.

Authors:  Laura A Martello; Raj Wadgaonkar; Raavi Gupta; Fabiana S Machado; Michael G Walsh; Eduardo Mascareno; Herbert B Tanowitz; M A Haseeb
Journal:  Parasitol Res       Date:  2013-09-10       Impact factor: 2.289

2.  Cavia porcellus as a model for experimental infection by Trypanosoma cruzi.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Noelia Angulo; Manuela Verastegui; Daniel E Velásquez; Charles R Sterling; Diana Martin; Caryn Bern
Journal:  Am J Pathol       Date:  2011-05-14       Impact factor: 4.307

3.  Genetic variant strains of Leishmania (Viannia) braziliensis exhibit distinct biological behaviors.

Authors:  Felipe Dutra Rêgo; Ana Cristina Vianna Mariano da Rocha Lima; Agnes Antônia Sampaio Pereira; Patrícia Flávia Quaresma; Marcelo Antônio Pascoal-Xavier; Jeffrey Jon Shaw; Célia Maria Ferreira Gontijo
Journal:  Parasitol Res       Date:  2018-07-18       Impact factor: 2.289

4.  Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy.

Authors:  Julián Ernesto Nicolás Gulin; Margarita María Catalina Bisio; Daniela Rocco; Jaime Altcheh; María Elisa Solana; Facundo García-Bournissen
Journal:  Front Cell Infect Microbiol       Date:  2022-07-05       Impact factor: 6.073

5.  Genes from Chagas susceptibility loci that are differentially expressed in T. cruzi-resistant mice are candidates accounting for impaired immunity.

Authors:  Sebastian E B Graefe; Thomas Streichert; Birgit S Budde; Peter Nürnberg; Christiane Steeg; Bertram Müller-Myhsok; Bernhard Fleischer
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

6.  Metallothionein-1 and nitric oxide expression are inversely correlated in a murine model of Chagas disease.

Authors:  Martha Elba Gonzalez-Mejia; Enrique Torres-Rasgado; Leonardo M Porchia; Hilda Rosas Salgado; José-Luis Totolhua; Arturo Ortega; Luisa Clara Regina Hernández-Kelly; Guadalupe Ruiz-Vivanco; Blanca G Báez-Duarte; Ricardo Pérez-Fuentes
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-02-17       Impact factor: 2.743

7.  Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.

Authors:  Guadalupe Andreani; Ana M Celentano; María E Solana; Silvia I Cazorla; Emilio L Malchiodi; Liliana A Martínez Peralta; Guillermina L Dolcini
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

Review 8.  Putting Infection Dynamics at the Heart of Chagas Disease.

Authors:  Michael D Lewis; John M Kelly
Journal:  Trends Parasitol       Date:  2016-09-06

9.  Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.

Authors:  Anthony W Ashton; Shankar Mukherjee; F N U Nagajyothi; Huan Huang; Vicki L Braunstein; Mahalia S Desruisseaux; Stephen M Factor; Lillie Lopez; Joan W Berman; Murray Wittner; Philipp E Scherer; Valerie Capra; Thomas M Coffman; Charles N Serhan; Katherine Gotlinger; Kenneth K Wu; Louis M Weiss; Herbert B Tanowitz
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

10.  Trypanosoma cruzi Entrance through Systemic or Mucosal Infection Sites Differentially Modulates Regional Immune Response Following Acute Infection in Mice.

Authors:  Juliana de Meis; Juliana Barreto de Albuquerque; Danielle Silva Dos Santos; Désio Aurélio Farias-de-Oliveira; Luiz Ricardo Berbert; Vinícius Cotta-de-Almeida; Wilson Savino
Journal:  Front Immunol       Date:  2013-07-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.